Harold Jacob - Director, Oramed Pharmaceuticals Inc

As of March 14, 2016


Harold Jacob Net Worth

  • Net worth is estimated to be at least $264.92K
  • Owns at least 17,096 units of Oramed Pharmaceuticals Inc stock
  • Sold an estimated value of $67.35K in the last 2 years at Oramed Pharmaceuticals Inc

Harold Jacob Trading

  • Largest purchase of shares was 700 units , worth over $10.09K on April 18, 2014
  • Largest sale of shares was 8,500 units , worth over $54.84K on March 14, 2016
  • In total has made about 6 transactions over 2 years
  • Usually trades in April, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Harold Jacob Mailing Address

  • Mailing address is Haadmur Mebuyon 26 Harnot Jerusalem L3 95403 Israel

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

Oramed Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 21,100 units sold on September 20, 2021 by Kevin Rakin worth over $442.83K
  • In the last 13 years, insiders at Oramed Pharmaceuticals Inc sold an estimated value of $12.02M and bought an estimated value of $6.08M
  • The most active traders are Miriam Kidron, Chief Scientific Officer,  Nadav Kidron, President and CEO,  and Leonard Sank, Director
  • Insider trading is most common in February, with the busiest year in 2014

ORAMED PHARMACEUTICALS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1